¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ Á¦ 17ȸ KSN-BRC (Board Review Course) 2024 - 1ÀÏÂ÷ : 2024-02-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽÅÀåÇÐȸ Á¦ 17ȸ KSN-BRC (Board Review Course) 2024 - 1ÀÏÂ÷ : 2024-02-24
±³À°ÀÏÀÚ : 2024-02-24
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ

±³À°ÁÖÁ¦ : Á¦ 17ȸ KSN-BRC (Board Review Course) 2024 - 1ÀÏÂ÷

ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736  

À̸ÞÀÏ : ksn@ksn.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 160,000¿ø  

ºñ°í BRC ÀüÀÏ: 160,000¿ø / BRC 1ÀÏ + ARC: 120,000¿ø / BRC 1ÀÏ: 80,000¿ø / ¸¸ 65¼¼ ÀÌ»ó, Çлý: ¸éÁ¦


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 09:00~09:30 Clnical Approach to Acid-base Disorder with Dyskalemia Á¤Áö¿ë(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 09:30~10:00 GFR evaluation and clinical application of biomarkers Â÷¶õÈñ(±¹¸³Áß¾ÓÀÇ·á¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 10:00~10:30 Phosphorus Hemeostasis and Hyperphosphatemia in CKD-MBD °í°­Áö(°í·ÁÀÇ´ë)

ÈÞ½Ä 02¿ù 24ÀÏ 10:30~10:40 ÈÞ½Ä ()

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 10:40~11:10 Initiation Time, Modality, and Adquate Dosing of RRT in ICU ÀÌÇϸ°(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 11:10~11:40 Stategy for CRRT Discontinuation ¾ÈÁ¤³²(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 11:40~12:10 Diagnosis and Treatment of Cardiorenal Syndrome (ARC ¿¬°è °­ÀÇ) ÀåÇý·Ã(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 12:10~12:40 Management of AKI in Cancer Patients ¹éÃæÈñ(¿ï»êÀÇ´ë)

½Ä»ç 02¿ù 24ÀÏ 12:40~13:30 ½Ä»ç ()

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 13:30~14:00 Genetic Glomerulopathy in Adult Patients (ARC ¿¬°è °­ÀÇ) À̹üÈñ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 14:00~14:30 Genetic Tubulopathy in Adult Patients Á¶Èñ¿¬(¼º±Õ°üÀÇ´ë)

ÈÞ½Ä 02¿ù 24ÀÏ 14:30~14:40 ÈÞ½Ä ()

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 14:40~15:10 Evaluation of the Potential Kidney Transplant Recipient and the Living Donor Á¶ÀåÈñ(°æºÏÀÇ´ë)

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 15:10~15:40 Transplant Pathology: Banff Classification ÀÓ¹üÁø(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 15:40~16:10 Treatment of Acute Rejection (ARC ¿¬°è °­ÀÇ) ½ÅÈ£½Ä(°í½ÅÀÇ´ë)

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 16:10~16:40 BK Virus Nephropathy ±è¸í±Ô(°í·ÁÀÇ´ë)

±³À°½Ã°£ 02¿ù 24ÀÏ ¸¶¸®¾ÆȦ 16:40~17:10 Recurrent Glomerular Diseases and Chronic Allograft Injury Á¤º´ÇÏ(°¡Å縯ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ Á¦ 17ȸ KSN-BRC (Board Review Course) 2024 - 1ÀÏÂ÷ : 2024-02-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â Á¦ 29ȸ ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰúÇб³½Ç ÃÊÀ½ÆÄ ¿öÅ©¼¥(óÀ½ ½ÃÀÛÇÏ´Â »ç¶÷µéÀ» À§ÇÑ »êºÎÀΰú ÃÊÀ½ÆÄÀÇ basic course) : 2024-02-24
´ÙÀ½±Û ±¹¸³Áß¾ÓÀÇ·á¿ø ÇǺΰú Á¦ 1ȸ Çмú´ëȸ : 2024-02-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21182 °æ±â Á¦6ȸ °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ¾Ï ½ÉÆ÷Áö¾ö(¿ÀÇÁ¶óÀÎ/¿Â¶óÀÎ) : 2024-07-26 0 6 2024-07-02
21181 ´ë±¸ Çѱ¹¿©ÀÚÀÇ»çȸ ´ë±¸°æºÏÁöȸ 7¿ù Çмú½ÉÆ÷Áö¾ö(ºÒ¸éÁõ, ¼ö¸éÁ¦, Ȳ¹Ýº¯¼º ¹× ³ëÈ­ °ü·Ã ¾ÈÁúȯ) : 2024-07-23 0 12 2024-07-02
21180 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø (¿Â¶óÀÎ) Á¦12ȸ ¼­¿ï ÀÓ»ó¾îÁö·³Áõ ¼¼¹Ì³ª : 2024-07-21 0 11 2024-07-02
21179 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ÇнÀÀå¾Ö ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-07-21 0 15 2024-07-02
21178 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°ú½ºÆ÷Ã÷ÀÇÇÐȸ - Á¦2Â÷ ½ºÆ÷Ã÷ ¼Õ»ó ½ÉÆ÷Áö¾ö : 2024-07-21 0 8 2024-07-02
21177 ¼­¿ï PH Korea 2024 with 4th EASOPH(Á¦9ȸ Æó°íÇ÷¾Ð Çмú´ëȸ) (2ÀÏÂ÷) : 2024-07-20 0 5 2024-07-02
21176 ¼­¿ï ´ëÇѽŰæ±Ù°ñ°áÃÊÀ½ÆÄÇÐȸ Á¦2ȸ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-07-20 0 7 2024-07-02
21175 ¼­¿ï 21st Head and Neck Workshop (»ï¼º¼­¿ïº´¿ø & ´ëÇѵΰæºÎ¿Ü°úÇÐȸ) : 2024-07-20 0 6 2024-07-02
21174 ¼­¿ï 2024 ´ëÇÑÈ£Èí°ü¸®ÇÐȸ Á¦32Â÷ Çмú´ëȸ : 2024-07-20 0 7 2024-07-02
21173 ¼­¿ï 2024³â ´ëÇÑ°íÇ÷¾ÐÇÐȸ ´ë»çÁõÈıº¿¬±¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-07-20 0 9 2024-07-02
21172 ¼­¿ï Á¦4ȸ ´ëÇѼÒÈ­±âÇÐȸ °æ±âÀÎõÁöȸ ½ÉÆ÷Áö¾ö ¹× ¿¬±¸°úÁ¦ ¹ßǥȸ : 2024-07-20 0 8 2024-07-02
21171 ¼¼Á¾ 2024³â ´ëÇÑ°í°üÀýÇÐȸ °üÀýº¸Á¸ ½ÉÆ÷Áö¿ò : 2024-07-20 0 6 2024-07-02
21170 ¿ï»ê 2024³â Á¦7ȸ ´ëÇÑÇ׳ëÈ­ºñ´¢ÅëÇÕ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-20 0 8 2024-07-02
21169 ¼­¿ï PH Korea 2024 with 4th EASOPH(Á¦9ȸ Æó°íÇ÷¾Ð Çмú´ëȸ) (1ÀÏÂ÷) : 2024-07-19 0 5 2024-07-02
21168 ¼­¿ï ´ëÇÑ»çȸÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-19 0 13 2024-07-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷